US Edition
Rocky Ford Family Raising Money for Possible Cure to Son’s Rare, Terminal Disease
- Experimental gene therapy for Fabry disease is saving treatment costs for patients, as reported by West.
- Three men treated for Fabry disease discontinued enzyme-replacement therapy, which costs about $300,000 annually, after starting gene therapy.
- Larger studies are needed before gene therapy can become a conventional treatment due to existing therapy's high costs and patient burden.
- The goal is to expand the study to include 25 to 30 patients over a two- to three-year period, according to West.
Insights by Ground AI
Does this summary seem wrong?
20 Articles
20 Articles
All
Left
9
Center
2
Right
Rocky Ford family raising money for possible cure to son’s rare, terminal disease
COLORADO SPRINGS, Colo. (KRDO) - A Rocky Ford family is sharing their story as they fight to save their young son’s life. Three-year-old Mason Matthews has a rare and terminal genetic condition called Mucolipidosis Type II, something most people have never heard of. Mason’s mom, Jaymie Matthews, said they first knew something was wrong at birth when their son was born full term, but couldn’t breathe on his own. "He had a very traumatic birth exp…
·Colorado Springs, United States
Read Full ArticleCoverage Details
Total News Sources20
Leaning Left9Leaning Right0Center2Last UpdatedBias Distribution82% Left
Bias Distribution
- 82% of the sources lean Left
82% Left
L 82%
C 18%
Factuality
To view factuality data please Upgrade to Premium
